slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1

Levosimendan legends - AHF

Archive of lectures on use of levosimendan in Acute decompensated heart failure recorded at European clinical congresses in 2016 and beyond

How to treat patients during deterioration of heart failure to avoid kidney dysfunction K Karason (Sweden) ESC-HF 2016

Why and how to use inodilators as a bridge to transplant or assist device F Gustafsson (Denmark) ESC-HF 2016

Why and how to treat patients in cardiogenic shock with inodilators F Guarracino (Italy) ESC-HF 2016

 

 

 

How to treat patients in acute heart failure to avoid kidney dysfunction Francesco Fedele (Italy) ESC-HF 2016

Levosimendan clinical use, patient quality of life John Parissis (Greece) ESC-HF 2015

Congestion: ino- or dilator? Prof Alexandre Mebazaa (France) ESC-HF 2015

 

 

 

Levosimendan: a unique mechanism of action Prof Ferenc Follath (Switzerland) ESC-HF 2015

How to interpret altered liver function tests in acute heart failure? Prof Alexandre Mebazaa (France) ISICEM 2015

Long-term effects of levosimendan on cytokines and neurohormones John Parissis (Greece)2014

 

 

 

The effect of levosimendan on the heart Geir Andersen (Norway) Levosimendan Lectures 2013

Effect of levosimendan on the kidney John Parissis (Greece) Levosimendan Lectures 2013

Effect of levosimendan on the liver Prof Alexandre Mebazaa (France) Levosimendan Lectures 2013